openPR Logo
Press release

Antibody Drug Conjugates Market Size Worth US$ 18.5 Billion Globally by 2027, at 23.8% CAGR

12-13-2022 12:33 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: IMARC Group

Antibody Drug Conjugates Market

Antibody Drug Conjugates Market

According to the latest report by IMARC Group, titled "Antibody Drug Conjugates Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global antibody drug conjugates market size reached a value of US$ 5.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 18.5 Billion by 2027, exhibiting at a CAGR of 23.8% during 2022-2027.

Antibody drug conjugates (ADCs) refer to highly potent biological drugs consisting of tumor-targeting antibodies, which are chemically bound to a cytotoxic effector molecule. They deliver anticancer agents to affected cells by connecting them to monoclonal antibodies (mAb) via biodegradable linkers and allowing sensitive bifurcation between diseased and healthy tissues. ACDs assist in enhancing drug tolerability, increasing the cell-killing potential of mAb, and limiting systematic exposure compared to standard chemotherapy bioactive compounds. As a result, these drugs find widespread applications across hospitals, specialized cancer centers, academic research institutes, biotechnology companies, etc.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report (Exclusive Offer on this report):

Antibody Drug Conjugates Market Trends:

The rising number of individuals smoking and drinking regularly, and the sedentary lifestyles are among the primary factors driving the antibody drug conjugates market. Besides this, the escalating demand for cost-effective and successful cancer treatments across the globe is further augmenting the market growth. Moreover, the extensive research and development (R&D) activities by the leading players to manufacture novel chemical triggers for generating stable and homogenous ADCs are also catalyzing the global market. Apart from this, the launch of additional linkers to allow the expansion of payloads and reduce off-target toxicity is acting as another significant growth-inducing factor. Furthermore, the expanding healthcare infrastructure, increasing awareness among the masses towards the therapies available for cancer treatments, and the introduction of cleavable technology are expected to bolster the antibody drug conjugates market in the coming years.

Competitive Landscape with Key Players:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market:

• ADC Therapeutics SA
• Astellas Pharma Inc.
• AstraZeneca plc
• Celldex Therapeutics Inc.
• Hoffmann-La Roche AG
• Gilead Sciences Inc.
• GlaxoSmithKline Plc
• ImmunoGen Inc
• Pfizer Inc.
• Sanofi S.A.
• Seagen Inc.
• Sorrento Therapeutics Inc.
• Takeda Pharmaceutical Company Ltd.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure:

Key Segmentation:

Breakup by Component:

• Monoclonal Antibodies
• Linker
• Cytotoxic Agent
• Others

Breakup by Target:

• Antibody-Protein Toxin Conjugates
• Antibody-Chelated Radionuclide Conjugates
• Antibody-Small-Molecule Drug Conjugates
• Antibody-Enzyme Conjugates

Breakup by Application:

• Lymphoma
• Ovarian Cancer
• Lung Cancer
• Breast Cancer
• Brain Tumor
• Others

Breakup by End User:

• Hospitals
• Specialized Cancer Centers
• Academic Research Institutes
• Biotechnology Companies
• Others

Breakup by Region:

• Middle East and Africa
• North America
• Asia-Pacific
• Europe
• Latin America

Key highlights of the Report:

• Market Performance
• Market Outlook
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antibody Drug Conjugates Market Size Worth US$ 18.5 Billion Globally by 2027, at 23.8% CAGR here

News-ID: 2846862 • Views: 231

More Releases from IMARC Group

Bridge Construction Market To Reach US$ 1,243.7 Million by 2028 | Growth Rate (C …
According to the latest report by IMARC Group, titled "Bridge Construction Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global bridge construction market size reached US$ 921.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,243.7 Million by 2028, exhibiting a growth rate (CAGR) of 4.89% during 2023-2028. Bridge construction is building a structure that spans a physical obstacle, such as
Smart Office Market To Reach US$ 83.2 Billion by 2028 | Growth Rate (CAGR) of 13 …
According to the latest report by IMARC Group, titled "Smart Office Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global smart office market size reached US$ 39.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 83.2 Billion by 2028, exhibiting a growth rate (CAGR) of 13% during 2023-2028. A smart office is a workplace that employs technology to optimize the use
Synthetic Lubricants Market Size, Sales Estimation, Top Leading Players and Busi …
According to IMARC Group latest report titled "Synthetic Lubricants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", offers a comprehensive analysis of the industry, which comprises insights on synthetic lubricants market. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global synthetic lubricants market reached a value of US$13.7 Billion in 2021. Looking forward, IMARC Group expects the market to
Tractor Market 2023-2028, Global Size, Share, Demand, Leading Players and Indust …
According to IMARC Group's latest report, titled "Tractor Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", the global tractor market is expected to exhibit a growth rate (CAGR) of 4.3% during 2023-2028. A tractor represents a specifically engineered vehicle designed to provide high torque at a slow speed. It comprises wheels, an engine, cooling, transmission, fuel, electrical and operator systems as standard components. Compared to regular trucks,

All 5 Releases

More Releases for Antibody

Antibody Engineering Services Market Size, Share | Industry Report, 2021-2027| F …
Complete study of the global Antibody Engineering Services market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Antibody Engineering Services industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They
Procalcitonin Antibody Market Report 2018: Segmentation by Type (Polyclonal Proc …
Global Procalcitonin Antibody market research report provides company profile for Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Shanghai Medicine'nest Pharmaceutical, Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for
Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | …
Complete Study of Monoclonal Antibody Custom Service Market Research Report is added on with Latest Advancement. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa. Avail Premium Sample Copy @ Monoclonal Antibody Custom Service Market – Overview It is estimated that monoclonal antibody custom service market is expected to
Global In-depth analysis and Growth of Market Study on Combination Antibody Ther …
"Global Market Study on Combination Antibody Therapy: Antibody/Antibody Combination Segment Expected to Dominate the Global Market Through 2024" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. .
Procalcitonin Antibody Market
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E.coli Scope of the Report: This report focuses on the Procalcitonin
Cancer Antibody Drug Conjugates Market Cancer Antibody Drug Conjugates Clinical …
For Report Sample Contact: or +91-11-47067990 Report Table of Contents Impetus of Antibody Drug Conjugates 1.1 Prologue to Cancer Antibody Drug Conjugate 1.2 The ABCs of ADCs Structural Entities of Antibody Drug Conjugate 2.1 Rational Design of Antibody Drug Conjugates 2.1.1 Monoclonal Antibody 2.1.2 Linker 2.1.3 Drug Payload 2.2 Aspects of Conjugational Chemistry Revolutionizing Antibody Drug Conjugates Generation